Literature DB >> 2056205

Antibacterial activity of crotalid venoms against oral snake flora and other clinical bacteria.

D A Talan1, D M Citron, G D Overturf, B Singer, P Froman, E J Goldstein.   

Abstract

Despite heavy oral and fang contamination of crotalid species with a wide variety of potentially pathogenic bacteria, crotalid envenomation is associated with a low incidence of bacterial infection. Minimal inhibitory and bactericidal concentrations of venoms from three crotalid species were determined against six aerobic and eight anaerobic reference and oral crotalid microorganisms. All anaerobic isolates were resistant to greater than 20,480 micrograms/ml, whereas variable activity (range, 5-20,480 micrograms/ml) was observed for aerobic strains. Further studies against other aerobic clinical isolates demonstrated that venom had the greatest activity (MIC, less than or equal to 80 micrograms/ml) against staphylococci, Pseudomonas aeruginosa, and Enterobacter, Citrobacter, Proteus, and Morganella species. Inhibitory activity was lost with prolonged incubation for many gram-negative species. Crotalid venoms are broadly active against aerobic gram-negative and -positive bacteria. This activity may play a role in the low incidence of infection after envenomation injuries.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2056205     DOI: 10.1093/infdis/164.1.195

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

Review 1.  Microbiology of animal bite wound infections.

Authors:  Fredrick M Abrahamian; Ellie J C Goldstein
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

2.  Bacterial Adaptation to Venom in Snakes and Arachnida.

Authors:  Elham Esmaeilishirazifard; Louise Usher; Carol Trim; Hubert Denise; Vartul Sangal; Gregory H Tyson; Axel Barlow; Keith F Redway; John D Taylor; Myrto Kremyda-Vlachou; Sam Davies; Teresa D Loftus; Mikaella M G Lock; Kstir Wright; Andrew Dalby; Lori A S Snyder; Wolfgang Wuster; Steve Trim; Sterghios A Moschos
Journal:  Microbiol Spectr       Date:  2022-05-23

3.  Clinical and biochemical changes in 53 Swedish dogs bitten by the European adder--Vipera berus.

Authors:  Jessica Berger Lervik; Inger Lilliehöök; Jan H M Frendin
Journal:  Acta Vet Scand       Date:  2010-04-23       Impact factor: 1.695

4.  In vitro antimicrobial activity of natural toxins and animal venoms tested against Burkholderia pseudomallei.

Authors:  R Perumal Samy; A Pachiappan; P Gopalakrishnakone; Maung M Thwin; Yap E Hian; Vincent T K Chow; Ho Bow; Joseph T Weng
Journal:  BMC Infect Dis       Date:  2006-06-20       Impact factor: 3.090

5.  Snake Venom: Any Clue for Antibiotics and CAM?

Authors:  Deivy Clementino de Lima; Paula Alvarez Abreu; Cícero Carlos de Freitas; Dilvani Oliveira Santos; Rodrigo Oliveira Borges; Tereza Cristina Dos Santos; Lúcio Mendes Cabral; Carlos R Rodrigues; Helena Carla Castro
Journal:  Evid Based Complement Alternat Med       Date:  2005-03       Impact factor: 2.629

6.  Cobra cytotoxins: structural organization and antibacterial activity.

Authors:  P V Dubovskii; Y N Utkin
Journal:  Acta Naturae       Date:  2014-07       Impact factor: 1.845

7.  Antibacterial Activity of Isolated Immunodominant Proteins of Naja Naja (Oxiana) Venom.

Authors:  Mahboobeh Talebi Mehrdar; Rasool Madani; Reza Hajihosseini; Soheila Moradi Bidhendi
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

Review 8.  Hitchhiking with Nature: Snake Venom Peptides to Fight Cancer and Superbugs.

Authors:  Clara Pérez-Peinado; Sira Defaus; David Andreu
Journal:  Toxins (Basel)       Date:  2020-04-15       Impact factor: 4.546

9.  Wound healing activity and mechanisms of action of an antibacterial protein from the venom of the eastern diamondback rattlesnake (Crotalus adamanteus).

Authors:  Ramar Perumal Samy; Matheswaran Kandasamy; Ponnampalam Gopalakrishnakone; Bradley G Stiles; Edward G Rowan; David Becker; Muthu K Shanmugam; Gautam Sethi; Vincent T K Chow
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.